Diabetes Blood Test Distributor GlycoMark
DOJ
False Claims Act
Penalty
$195,000
Outcome
Diabetes Blood Test Distributor GlycoMark Agrees to Pay $195,000 to Settle False Claims Act Allegations
Details
Diabetes Blood Test Distributor GlycoMark — DOJ Enforcement (2023)
DOJ took enforcement action against Diabetes Blood Test Distributor GlycoMark in PA in 2023 involving false claims act violations in the Clinical Laboratories sector.
Penalty: $195,000
Violation types: False Claims Act
Entity type: Clinical Laboratory
Penalty type: Settlement
Location: PA
Source: DOJ Press Release — Diabetes Blood Test Distributor GlycoMark Agrees to Pay $195,000 to Settle False Claims Act Allegations
How Crucible Prevents This
Crucible's billing compliance controls enforce documentation-to-claims reconciliation and flag billing anomalies before false claims are submitted.
Don't let this happen to your organization. See how Crucible works.
See How Crucible Works